Dct Industrial Trust Inc (DCT) 49.36 $DCT Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dct Industrial Trust Inc (DCT) 49.36 $DCT

Uptrend Call Working As DCT Industrial Trust Stock Rises 39.9% (DCT)
Comtex SmarTrend(R) - Fri Jul 29, 12:53PM CDT
SmarTrend identified an Uptrend for DCT Industrial Trust (NYSECT) on February 5th, 2016 at $36.13. In approximately 6 months, DCT Industrial Trust has returned 39.91% as of today's recent price of $50.55.
DCT: 49.36 (-0.24)

33.6% Return Seen to Date on SmarTrend DCT Industrial Trust Call (DCT)
Comtex SmarTrend(R) - Thu Jul 14, 12:50PM CDT
SmarTrend identified an Uptrend for DCT Industrial Trust (NYSECT) on February 5th, 2016 at $36.13. In approximately 5 months, DCT Industrial Trust has returned 33.63% as of today's recent price of $48.28.
DCT: 49.36 (-0.24)

DCT Industrial Starts Construction of Arbor Avenue in Tracy
Zacks Equity Research - Zacks Investment Research - Thu Jul 14, 5:14AM CDT
DCT Industrial Trust Inc. (DCT) announced the groundbreaking of DCT Arbor Avenue.
DCT: 49.36 (-0.24), WPC: 70.32 (-1.08), COR: 80.47 (+0.39), EQC: 29.76 (-0.19)

DCT Industrial Trust(R) Breaks Ground on 796,000 Square Foot Development in Tracy, CA
BusinessWire - Wed Jul 13, 3:10PM CDT
DCT Industrial Trust(R) (NYSE: DCT), a leading industrial real estate company announced today the groundbreaking of DCT Arbor Avenue, a 796,000 square foot development located on 39.6 acres in the City of Tracy in San Joaquin County, in the Central Valley of Northern California.
DCT: 49.36 (-0.24)

Thomas F. August Named CEO of DDR
PR Newswire - Mon Jul 11, 6:45AM CDT
DDR Corp. (NYSE: DDR) announced today that DDR Board member Thomas F. August was named President & Chief Executive Officer, effective immediately. The appointment of Mr. August follows the termination of David J. Oakes as President & Chief Executive Officer and as interim Chief Financial Officer. Mr. Oakes' termination was not related to the Company's financial or operating results or to any disagreements or concerns regarding the Company's financial or reporting practices.
DCT: 49.36 (-0.24), DDR: 19.47 (+0.03), DKS: 51.81 (+0.39)

Boston Properties Completes Colorado Center Stake Buyout
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 9:26AM CDT
Boston Properties Inc. (BXP) has completed the acquisition of 49.8% stake in the Colorado Center in Santa Monica, CA. The move marked the company's foray into the Westside Los Angeles market.
DCT: 49.36 (-0.24), BXP: 140.52 (+0.11), PSB: 110.26 (+1.52), CLI: 27.71 (-0.19)

CoreSite (COR) Seals Distribution Deal with Ingram Micro
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 7:59AM CDT
CoreSite Realty (COR) and Ingram Micro (IM) signed a distribution agreement that would enable Ingram Micro to offer CoreSite's data center colocation services and solutions.
DCT: 49.36 (-0.24), IM: 33.81 (-0.42), PSB: 110.26 (+1.52), COR: 80.47 (+0.39)

CoreSite (COR) Chosen to Expand Paperspace Cloud Platform
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:13AM CDT
The data center REIT, CoreSite Realty Corporation (COR), has been chosen by Paperspace to meet the requirements of its newly launched cloud computing platform.
DCT: 49.36 (-0.24), DEI: 37.58 (+0.06), PSB: 110.26 (+1.52), COR: 80.47 (+0.39)

Prologis Planning Multi-Story Development in South Seattle
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:42AM CDT
Prologis Inc. (PLD) is planning to come up with a multi-story development in South Seattle, according to a business journal.
DCT: 49.36 (-0.24), DEI: 37.58 (+0.06), PSB: 110.26 (+1.52), PLD: 53.87 (-0.19)

Gladstone Commercial Achieves 98.5% Portfolio Occupancy
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:38AM CDT
Gladstone Commercial Corporation (GOOD) disclosed signing of three news leases that has helped the company achieve portfolio occupancy to 98.5%.
DCT: 49.36 (-0.24), GOOD: 17.60 (-0.03), DEI: 37.58 (+0.06), PSB: 110.26 (+1.52)

Why REITs Are Preferred Investments Right Now
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 3:39PM CDT
Why REITs Are Preferred Investments Right Now
MPW: 15.35 (+0.06), IVR: 14.84 (+0.05), ROIC: 22.37 (-0.09), AHH: 13.99 (-0.04), APLE: 20.01 (+0.02), PSB: 110.26 (+1.52), CLI: 27.71 (-0.19), COR: 80.47 (+0.39), WSR: 15.19 (unch), UE: 29.39 (+0.07), ELS: 80.07 (-1.02), EDR: 47.17 (-0.83), CTRE: 14.13 (+0.02), DCT: 49.36 (-0.24), INN: 13.89 (-0.16), KIM: 31.24 (-0.21), BFS: 66.06 (+0.40), WPC: 70.32 (-1.08), TWO: 8.81 (+0.03)

One Liberty Properties Buys El Paso Distribution Facility
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:37AM CDT
One Liberty Properties, Inc. (OLP) disclosed the acquisition of a distribution facility in El Paso, TX. The company has shelled out $23.7 million for the purchase.
DCT: 49.36 (-0.24), OLP: 24.39 (-0.01), DEI: 37.58 (+0.06), PSB: 110.26 (+1.52)

Iron Mountain Announces Resignation of CFO Rod Day and Appointment of Stuart Brown
BusinessWire - Wed Jun 15, 5:55AM CDT
Iron Mountain Incorporated (NYSE: IRM), the storage and information management company, today announced that Roderick Day, the company's executive vice president and chief financial officer, will leave the company due to personal reasons that do not permit him to permanently relocate his family to Boston, as originally contemplated. Day will step down from his role as executive vice president and CFO immediately following the filing of its quarterly report on Form 10-Q for the quarter ending June 30, 2016, but will remain with the company through mid-October for transition purposes. Day, 52, has served as Iron Mountain's CFO since November 2013. He joined the company in 2008 and was previously senior vice president and CFO, International.
DCT: 49.36 (-0.24), IRM: 38.02 (-2.22)

SL Green Signs Renewal, Expansion Deal with New York Life
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:08AM CDT
SL Green Realty Corp. (SLG) disclosed signing a 10-year renewal and expansion lease deal with New York Life Insurance Company at the Graybar Building.
DCT: 49.36 (-0.24), SLG: 116.92 (+0.64), PSB: 110.26 (+1.52), CLI: 27.71 (-0.19)

Prologis Reaps $1.6B in Proceeds, Exceeds Target Mid-Point
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 7:16AM CDT
Prologis Inc. (PLD) has reaped proceeds of $1.6 billion since the start of 2016 through May 31, from non-strategic dispositions, fund contributions and fund rebalance.
DCT: 49.36 (-0.24), FB: 124.30 (+1.79), PSB: 110.26 (+1.52), PLD: 53.87 (-0.19)

Why These REITs Fascinate Investors? - CubeSmart, DCT Industrial Trust, Public Storage, and STAG Industrial
PR Newswire - Fri Jun 03, 7:20AM CDT
Global industrial property demand continues to grow at a steady pace, meeting expectations and making Industrial REITs stocks potential candidates for those looking to add new components to their investment mix. Today, ActiveWallSt.com would like for investors to check out these names: CubeSmart (NYSE: CUBE), DCT Industrial Trust Inc. (NYSE: DCT), Public Storage (NYSE: PSA), and STAG Industrial Inc. (NYSE: STAG). Learn more about these stocks by accessing their free trade alerts at:
STAG: 25.00 (+0.30), DCT: 49.36 (-0.24), PSA: 230.12 (-3.33), CUBE: 27.65 (-1.24)

American Tower (AMT): Will Organic Growth Offset Headwinds?
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 5:08PM CDT
On Jun 2, we issued an updated research report on leading international wireless tower operator American Tower Corp. (AMT).
DCT: 49.36 (-0.24), APLE: 20.01 (+0.02), AMT: 116.20 (+0.47), COR: 80.47 (+0.39)

DCT Industrial Trust(R) Announces $250 Million Senior Unsecured Notes Transaction
BusinessWire - Tue May 31, 3:10PM CDT
DCT Industrial Trust(R) (NYSE: DCT), a leading industrial real estate company, today announced that it has agreed in principle to issue $250 million of senior unsecured notes. The senior unsecured notes will be issued in a private placement offering with an average term of 10 years and a weighted-average interest rate of 3.90 percent. The notes, which require semi-annual payments of interest only, consist of $80 million of notes maturing in 2024 with a fixed interest rate of 3.75 percent, $90 million of notes maturing in 2026 with a fixed interest rate of 3.92 percent and $80 million of notes maturing in 2028 with a fixed interest rate of 4.02 percent. The transaction is expected to close in August 2016, with proceeds expected to be used to repay borrowings under our senior unsecured revolving line of credit, other senior unsecured notes and for general corporate purposes.
DCT: 49.36 (-0.24)

Rayonier (RYN) to Gain from Portfolio Revamp: Time to Hold?
Zacks Equity Research - Zacks Investment Research - Fri May 27, 8:50AM CDT
We updated our research report on Rayonier Inc. (RYN) on May 26, 2016.
DCT: 49.36 (-0.24), RYN: 26.90 (+0.01), PSB: 110.26 (+1.52), WSR: 15.19 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading